Bio Fund Management Ltd. signed an agreement to acquire 100% stake in Kardiolytics Inc. for $44.9 million on October 3, 2022. Bio Fund to also provide company with additional financing of up to $2.8 million (PLN 13.8 million) over three year period from share purchase.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.04 PLN | -0.84% | +0.39% | -14.76% |
04-22 | Medicalgorithmics S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Medicalgorithmics S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-14.76% | 66.19M | |
-12.09% | 19.25B | |
-38.46% | 2.96B | |
+22.02% | 1.96B | |
-0.62% | 1.69B | |
+33.51% | 1.27B | |
-16.17% | 982M | |
-22.01% | 913M | |
+5.38% | 801M | |
-23.80% | 630M |
- Stock Market
- Equities
- MDG Stock
- News Medicalgorithmics S.A.
- Bio Fund Management Ltd. signed an agreement to acquire 100% stake in Kardiolytics Inc. for $44.9 million.